Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...

Mumbai: Mumbai-based pharma giant Cipla is gearing up to make an entry into India's rapidly growing weight management market, ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and ...

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has said.

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

A collection of top researchers have made the case for a new way to understand and diagnose obesity beyond using BMI as a measure.